Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-01-04 Sale |
2024-01-04 9:35 pm |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
15,000 | $17.9 | $268,500 | 335,730 (Direct) |
View |
| 2023-05-16 Sale |
2023-05-18 6:31 pm |
Viking Therapeutics Inc. | VKTX | Rowland Charles A Jr Director |
40,000 | $25 | $1,000,000 | 30,000 (Direct) |
View |
| 2023-05-16 Sale |
2023-05-18 6:30 pm |
Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director |
16,000 | $24 | $384,000 | 47,965 (Direct) |
View |
| 2023-05-01 Sale |
2023-05-01 7:03 pm |
Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO |
45,000 | $22.45 | $1,010,250 | 2,197,963 (Direct) |
View |
| 2023-04-24 Sale |
2023-04-24 7:31 pm |
Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director |
16,000 | $22 | $352,061 | 47,965 (Direct) |
View |
| 2023-04-19 Sale |
2023-04-21 7:29 pm |
Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO |
35,000 | $21.45 | $750,750 | 2,242,963 (Direct) |
View |
| 2023-04-17 Sale |
2023-04-18 7:10 pm |
Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director |
20,786 | $20 | $415,720 | 47,965 (Direct) |
View |
| 2023-04-17 Sale |
2023-04-18 7:09 pm |
Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO |
155,000 | $20.45 | $3,169,766 | 2,277,963 (Direct) |
View |
| 2023-04-17 Sale |
2023-04-18 7:08 pm |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
12,500 | $20 | $250,000 | 287,763 (Direct) |
View |
| 2023-04-17 Sale |
2023-04-18 7:07 pm |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
7,500 | $20 | $150,000 | 149,279 (Direct) |
View |
| 2023-04-13 Sale |
2023-04-13 5:14 pm |
Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO |
79,336 | $18.45 | $1,463,749 | 2,307,963 (Direct) |
View |
| 2023-04-11 Sale |
2023-04-13 5:13 pm |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
97,839 | $18 | $1,761,310 | 366,823 (Direct) |
View |
| 2023-03-30 Sale |
2023-04-03 7:26 pm |
Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO |
243,352 | $17.31 | $4,211,292 | 2,535,081 (Direct) |
View |
| 2023-03-30 Sale |
2023-04-03 7:24 pm |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
161,940 | $17.19 | $2,784,219 | 149,279 (Direct) |
View |
| 2023-03-28 Sale |
2023-03-30 9:04 pm |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
237,805 | $15.17 | $3,608,317 | 261,895 (Direct) |
View |
| 2022-05-02 Purchase |
2022-05-03 4:12 pm |
Viking Therapeutics Inc. | VKTX | FOEHR MATTHEW W Director |
45,000 | $2.471 | $111,195 | 111,250 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-01-03 Option Award |
2024-01-04 9:36 pm |
2025-01-03 2034-01-03 |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
253,334 | $0 | 488,799 (Direct) |
View |
| 2024-01-04 Tax Withholding |
2024-01-04 9:36 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
14,199 | $18.58 | 488,799 (Direct) |
View |
| 2024-01-03 Tax Withholding |
2024-01-04 9:36 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
49,210 | $17.4 | 488,799 (Direct) |
View |
| 2024-01-03 Option Award |
2024-01-04 9:35 pm |
2025-01-03 2034-01-03 |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
253,334 | $0 | 335,730 (Direct) |
View |
| 2024-01-04 Tax Withholding |
2024-01-04 9:35 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
13,872 | $18.58 | 335,730 (Direct) |
View |
| 2024-01-03 Tax Withholding |
2024-01-04 9:35 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
49,122 | $17.4 | 335,730 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 9:28 pm |
2025-01-02 2034-01-02 |
Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director |
32,000 | $0 | 32,000 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 9:27 pm |
2025-01-02 2034-01-02 |
Viking Therapeutics Inc. | VKTX | Rowland Charles A Jr Director |
32,000 | $0 | 32,000 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 9:25 pm |
2025-01-02 2034-01-02 |
Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director |
32,000 | $0 | 32,000 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 9:24 pm |
2025-01-02 2034-01-02 |
Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director |
32,000 | $0 | 32,000 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 9:22 pm |
2025-01-02 2034-01-02 |
Viking Therapeutics Inc. | VKTX | FOEHR MATTHEW W Director |
32,000 | $0 | 32,000 (Direct) |
View |
| 2023-05-16 Exercise |
2023-05-18 6:31 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Rowland Charles A Jr Director |
40,000 | $1.08 | 30,000 (Direct) |
View |
| 2023-05-16 Exercise |
2023-05-18 6:31 pm |
2018-07-01 2027-07-01 |
Viking Therapeutics Inc. | VKTX | Rowland Charles A Jr Director |
40,000 | $0 | 30,000 (Direct) |
View |
| 2023-05-16 Exercise |
2023-05-18 6:30 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director |
16,000 | $1.19 | 47,965 (Direct) |
View |
| 2023-05-16 Exercise |
2023-05-18 6:30 pm |
2018-01-03 2027-01-03 |
Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director |
16,000 | $0 | 47,965 (Direct) |
View |
| 2023-04-24 Exercise |
2023-04-24 7:31 pm |
2017-01-04 2026-01-04 |
Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director |
16,000 | $0 | 47,965 (Direct) |
View |
| 2023-04-24 Exercise |
2023-04-24 7:31 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director |
16,000 | $3.33 | 47,965 (Direct) |
View |
| 2023-04-17 Exercise |
2023-04-18 7:10 pm |
2016-05-26 2025-04-28 |
Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director |
20,786 | $0 | 47,965 (Direct) |
View |
| 2023-04-17 Exercise |
2023-04-18 7:10 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director |
20,786 | $8 | 47,965 (Direct) |
View |
| 2023-04-17 Exercise |
2023-04-18 7:09 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO |
125,000 | $2.15 | 2,277,963 (Direct) |
View |
| 2023-04-17 Exercise |
2023-04-18 7:09 pm |
2017-03-04 2026-03-04 |
Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO |
125,000 | $0 | 2,277,963 (Direct) |
View |
| 2023-04-17 Exercise |
2023-04-18 7:08 pm |
2018-08-31 2018-08-31 |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
12,500 | $0 | 287,763 (Direct) |
View |
| 2023-04-17 Exercise |
2023-04-18 7:08 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
12,500 | $13.07 | 287,763 (Direct) |
View |
| 2023-04-17 Exercise |
2023-04-18 7:07 pm |
2018-08-31 2028-08-31 |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
7,500 | $0 | 149,279 (Direct) |
View |
| 2023-04-17 Exercise |
2023-04-18 7:07 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
7,500 | $13.07 | 149,279 (Direct) |
View |
| 2023-04-13 Exercise |
2023-04-13 5:14 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO |
54,336 | $1.88 | 2,307,963 (Direct) |
View |
| 2023-04-13 Exercise |
2023-04-13 5:14 pm |
2016-03-14 2026-03-14 |
Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO |
54,336 | $0 | 2,307,963 (Direct) |
View |
| 2023-04-11 Exercise |
2023-04-13 5:13 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
7,339 | $7.77 | 366,823 (Direct) |
View |
| 2023-04-11 Exercise |
2023-04-13 5:13 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
30,000 | $4.88 | 366,823 (Direct) |
View |
| 2023-04-11 Exercise |
2023-04-13 5:13 pm |
2021-01-03 2030-01-03 |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
97,839 | $0 | 366,823 (Direct) |
View |
| 2023-04-11 Exercise |
2023-04-13 5:13 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
52,000 | $5.8 | 366,823 (Direct) |
View |
| 2023-04-11 Exercise |
2023-04-13 5:13 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
8,500 | $4.68 | 366,823 (Direct) |
View |
| 2023-04-03 Option Award |
2023-04-03 7:26 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO |
300,000 | $0 | 2,535,081 (Direct) |
View |
| 2023-04-03 Tax Withholding |
2023-04-03 7:26 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO |
200,000 | $17.57 | 2,535,081 (Direct) |
View |
| 2023-03-30 Exercise |
2023-04-03 7:26 pm |
2018-01-05 2027-01-05 |
Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO |
203,352 | $0 | 2,535,081 (Direct) |
View |
| 2023-03-30 Exercise |
2023-04-03 7:26 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO |
87,500 | $9.49 | 2,535,081 (Direct) |
View |
| 2023-03-30 Exercise |
2023-04-03 7:26 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO |
115,852 | $1.23 | 2,535,081 (Direct) |
View |
| 2023-03-30 Exercise |
2023-04-03 7:24 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
32,000 | $8.52 | 149,279 (Direct) |
View |
| 2023-04-03 Exercise |
2023-04-03 7:24 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
30,911 | $7.77 | 149,279 (Direct) |
View |
| 2023-04-03 Option Award |
2023-04-03 7:24 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
56,667 | $0 | 149,279 (Direct) |
View |
| 2023-04-03 Tax Withholding |
2023-04-03 7:24 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
55,166 | $17.57 | 149,279 (Direct) |
View |
| 2023-03-30 Exercise |
2023-04-03 7:24 pm |
2020-01-15 2029-01-15 |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
124,661 | $0 | 149,279 (Direct) |
View |
| 2023-03-30 Exercise |
2023-04-03 7:24 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
42,000 | $7.69 | 149,279 (Direct) |
View |
| 2023-03-30 Exercise |
2023-04-03 7:24 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
7,500 | $4.12 | 149,279 (Direct) |
View |
| 2023-03-30 Exercise |
2023-04-03 7:24 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
12,250 | $4.65 | 149,279 (Direct) |
View |
| 2023-03-30 Exercise |
2023-04-03 7:22 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
23,100 | $8.52 | 288,763 (Direct) |
View |
| 2023-03-30 Exercise |
2023-04-03 7:22 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
36,100 | $17.01 | 288,763 (Direct) |
View |
| 2023-03-30 Option Award |
2023-04-03 7:22 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
56,667 | $0 | 288,763 (Direct) |
View |
| 2023-03-30 Tax Withholding |
2023-04-03 7:22 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
30,799 | $17.57 | 288,763 (Direct) |
View |
| 2023-03-30 Exercise |
2023-04-03 7:22 pm |
2020-01-15 2029-01-15 |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
36,100 | $0 | 288,763 (Direct) |
View |
| 2023-03-30 Exercise |
2023-04-03 7:22 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
10,000 | $7.69 | 288,763 (Direct) |
View |
| 2023-03-30 Exercise |
2023-04-03 7:22 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
3,000 | $6.47 | 288,763 (Direct) |
View |
| 2023-03-28 Exercise |
2023-03-30 9:04 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
4,873 | $1.88 | 261,895 (Direct) |
View |
| 2023-03-28 Exercise |
2023-03-30 9:04 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
10,000 | $1.04 | 261,895 (Direct) |
View |
| 2023-03-28 Exercise |
2023-03-30 9:04 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
15,000 | $2.15 | 261,895 (Direct) |
View |
| 2023-03-28 Exercise |
2023-03-30 9:04 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
15,000 | $1.08 | 261,895 (Direct) |
View |
| 2023-03-28 Exercise |
2023-03-30 9:04 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
30,000 | $4.37 | 261,895 (Direct) |
View |
| 2023-03-28 Exercise |
2023-03-30 9:04 pm |
2017-03-04 2026-03-04 |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
182,427 | $0 | 261,895 (Direct) |
View |
| 2023-03-28 Exercise |
2023-03-30 9:04 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
53,054 | $1.23 | 261,895 (Direct) |
View |
| 2023-03-28 Exercise |
2023-03-30 9:04 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
24,500 | $4.65 | 261,895 (Direct) |
View |
| 2023-03-29 Exercise |
2023-03-30 9:04 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
15,000 | $9.13 | 261,895 (Direct) |
View |
| 2023-03-28 Exercise |
2023-03-30 9:04 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
15,000 | $1.26 | 261,895 (Direct) |
View |
| 2023-01-15 Tax Withholding |
2023-01-17 7:39 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
1,079 | $8.95 | 317,273 (Direct) |
View |
| 2023-01-03 Tax Withholding |
2023-01-04 6:25 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
23,933 | $8.52 | 389,057 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-04 6:25 pm |
2024-01-03 2033-01-03 |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
314,900 | $0 | 389,057 (Direct) |
View |
| 2023-01-04 Tax Withholding |
2023-01-04 6:25 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
20,708 | $8.42 | 389,057 (Direct) |
View |
| 2022-12-30 Tax Withholding |
2023-01-04 6:25 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
19,697 | $9.4 | 389,057 (Direct) |
View |
| 2023-01-03 Tax Withholding |
2023-01-04 6:24 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
18,854 | $8.52 | 522,352 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-04 6:24 pm |
2024-01-03 2033-01-03 |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
318,167 | $0 | 522,352 (Direct) |
View |
| 2023-01-04 Tax Withholding |
2023-01-04 6:24 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
13,994 | $8.42 | 522,352 (Direct) |
View |
| 2022-12-30 Tax Withholding |
2023-01-04 6:24 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
12,773 | $9.4 | 522,352 (Direct) |
View |
| 2023-01-03 Tax Withholding |
2023-01-04 6:24 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO |
68,252 | $8.52 | 2,872,963 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-04 6:24 pm |
2024-01-03 2033-01-03 |
Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO |
988,334 | $0 | 2,872,963 (Direct) |
View |
| 2023-01-04 Tax Withholding |
2023-01-04 6:24 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO |
28,619 | $8.42 | 2,872,963 (Direct) |
View |
| 2022-12-30 Tax Withholding |
2023-01-04 6:24 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO |
66,127 | $9.4 | 2,872,963 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-04 6:13 pm |
2024-01-03 2033-01-03 |
Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-04 6:12 pm |
2024-01-03 2033-01-03 |
Viking Therapeutics Inc. | VKTX | Rowland Charles A Jr Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-04 6:11 pm |
2024-01-03 2033-01-03 |
Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-04 6:11 pm |
2024-01-03 2033-01-03 |
Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-04 6:03 pm |
2024-01-03 2033-01-03 |
Viking Therapeutics Inc. | VKTX | FOEHR MATTHEW W Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2022-01-15 Tax Withholding |
2022-02-11 6:34 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
827 | $4.24 | 238,695 (Direct) |
View |
| 2022-01-04 Tax Withholding |
2022-01-05 7:13 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
8,835 | $4.62 | 256,304 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 7:13 pm |
2023-01-03 2032-01-03 |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
173,333 | $0 | 256,304 (Direct) |
View |
| 2022-01-03 Tax Withholding |
2022-01-05 7:13 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
3,097 | $4.88 | 256,304 (Direct) |
View |
| 2022-01-04 Tax Withholding |
2022-01-05 7:12 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
11,845 | $4.62 | 413,522 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 7:12 pm |
2023-01-03 2032-01-03 |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
251,333 | $0 | 413,522 (Direct) |
View |
| 2022-01-03 Tax Withholding |
2022-01-05 7:12 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
3,919 | $4.88 | 413,522 (Direct) |
View |
| 2022-01-04 Tax Withholding |
2022-01-05 7:12 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO |
26,432 | $4.62 | 2,426,686 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 7:12 pm |
2023-01-03 2032-01-03 |
Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO |
563,333 | $0 | 2,426,686 (Direct) |
View |
| 2022-01-03 Tax Withholding |
2022-01-05 7:12 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO |
36,319 | $4.88 | 2,426,686 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 7:11 pm |
2023-01-03 2032-01-03 |
Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 7:11 pm |
2023-01-03 2032-01-03 |
Viking Therapeutics Inc. | VKTX | Rowland Charles A Jr Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 7:10 pm |
2023-01-03 2032-01-03 |
Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 7:09 pm |
2023-01-03 2032-01-03 |
Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director |
22,000 | $0 | 22,000 (Direct) |
View |